REBECCA DENNISTON: Open Payments
NPI 1811363070 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,094 in 91 payments from 14 companies in 2025. Trend: 2023 $1,730 · 2024 $1,781 · 2025 $2,094
Food & beverage: $1,995Education: $99
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 11 | $309 |
| Novartis Pharmaceuticals Corporation | 8 | $277 |
| UCB, Inc. | 8 | $255 |
| Lilly USA, LLC | 13 | $213 |
| ABBVIE INC. | 11 | $208 |
| Janssen Biotech, Inc. | 10 | $190 |
| E.R. Squibb & Sons, L.L.C. | 10 | $148 |
| PFIZER INC. | 6 | $113 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $112 |
| Eli Lilly and Company | 1 | $99 |
Products named: ADBRY, Bimzelx, TALTZ, TREMFYA, Rhapsido, SKYRIZI, Sotyktu, CIBINQO.
Industry payments across AR — which companies pay providers there.
